From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
|Articles|October 12, 2021
Pharmacist Medication Insights: Fluciclovine F 18 (Axumin) for Prostate Cancer
Author(s)Saro Arakelians, PharmD
Fluciclovine F 18 (Axumin), which is a radioactive diagnostic agent for injection that can be used to detect recurring prostate cancer.
Advertisement
Fluciclovine F 18 (Axumin), a radioactive diagnostic agent for injection that can be used to detect recurring prostate cancer, was
Clinical studies demonstrated that Axumin for imaging prostate cancer in men with high PSA levels following prior treatment was safe and effective. However, since Axumin is a radioactive drug, health care professionals should be careful about minimizing radiation exposure.
Advertisement
Related to this article
Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
The FDA expanded approval of talazoparib plus enzalutamide to HRR-mutated metastatic androgen pathway modulation-naïve or -sensitive prostate cancer following a significant radiographic PFS benefit in TALAPRO-3.
Before lung cancer therapy begins, diagnostic findings and treatment readiness shape care, creating opportunities for pharmacists to help patients start safely.
October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
October’s hematology coverage highlighted first-line pirtobrutinib, questions about myeloma treatment duration and early intervention, and pharmacists’ roles in medication safety and access.
October’s oncology coverage highlighted new treatment options in rectal, breast, and prostate cancers, alongside longer-term survival findings and concerns about reduced-frequency immunotherapy.
Advertisement
Advertisement
Trending on Pharmacy Times
1
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
2
Nicotine Vaping Linked to Lower Vascular Function in Young Adults
3
Over Half of RSV-Related Deaths in Hospitalized Adults Occur After Discharge
4
What Happens Before the First Dose? 5 Steps That Shape Lung Cancer Treatment
5